A <i>Streptomyces</i> megacluster encodes synergistic biotin-targeting antibiotics

Researchers identified a megacluster in *Streptomyces* species that produces multiple distinct antimicrobials. These compounds work together to target bacterial biotin biosynthesis, functioning as a naturally evolved combination therapy. The study, published in Nature on June 24, 2026, details how this gene cluster enables a synergistic attack on a vital metabolic pathway in bacteria. This discovery offers insights into novel strategies for combating antibiotic resistance by mimicking nature's own multi-pronged approaches to drug development. The specific mechanisms by which these diverse antimicrobials converge on biotin synthesis were elucidated, highlighting the evolutionary advantage of such integrated biosynthetic pathways. The findings suggest potential avenues for developing new antibiotic treatments that are less susceptible to resistance development due to their multi-target nature.